<DOC>
	<DOCNO>NCT02186483</DOCNO>
	<brief_summary>The purpose study investigate pharmacokinetic drug interaction Metformin Rosuvastatin healthy male volunteer .</brief_summary>
	<brief_title>Clinical Trial Investigate Pharmacokinetics Drug Interaction Between Metformin Rosuvastatin</brief_title>
	<detailed_description>Drug-drug Interaction Following Co-administration Metformin Rosuvastatin Healthy Male Volunteers</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>19~55 year healthy male BMI measurement 19.0kg/m^2~ 28.0kg/m^2 Signed inform consent form participate voluntarily comply trial requirement . History clinically significant kidney , liver , gastrointestinal system , cardiovascular system , respiratory system , tumor blood disorder , nervous system , immune system , endocrine disorder , cardiovascular disease , mental disorder ( mood disorder , obsessivecompulsive disorder , etc . ) SBP &gt; 140mmHg &lt; 90mmHg , DBP &gt; 90mmHg &lt; 60mmHg . An impossible one participant clinical trial investigator 's decision include laboratory test result another reason . History drug abuse A alcohol consumer ( alcohol &gt; 140g/week ) smoker ( cigarette &gt; 10 cigarettes/day ) Hypersensitivity reaction history investigational drug specific drug ( aspirin , antibiotic ) Administrated investigational product previous clinical trial within 60 day screen day study . Administrated drug inhibit induce OCT2 , OATP1B1 transporter within 30 day screen day study . ( ex : proton pump inhibitor , rifampicin ) Glomerular filtration rate &lt; 60mL/min Donated blood within 60 day prior screen day apheresis blood within 30 day prior screen day .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>